Literature DB >> 12742330

Factor V Leiden in pregnancies complicated by placental abruption.

Martin Procházka1, Catharina Happach, Karel Marsál, Björn Dahlbäck, Pelle G Lindqvist.   

Abstract

OBJECTIVE: Recent studies suggest an increased prevalence of obstetric complications in female carriers of hereditary or acquired thrombophilias. The aim of the study was to determine if carriership of the factor V (FV) Leiden mutation (activated protein C [APC] resistance) is higher in women who have had of placental abruption during pregnancy.
DESIGN: A retrospective case-control study.
SETTING: University Hospital MAS, Malmö, Sweden.
METHODS: A comparison of 102 women with placental abruption with 2371 prospectively collected controls. Carriership of FV Leiden was determined and the women were interviewed. MAIN OUTCOME MEASURES: Proportion of FV Leiden carriership, first degree heritage of thrombosis and previous placental abruption in cases and controls.
RESULTS: Carriage of FV Leiden was found in 15.7% of women who have had placental abruption as compared with 10.8% of controls (P = 0.12, odds ratio [OR] = 1.5, 95% confidence interval [CI] = 0.9-2.7). Around 20% of women with placental abruption reported first degree heritage for venous thrombosis, as compared with 6.7% of controls (P < or = 0.001).
CONCLUSIONS: FV Leiden carriership was not significantly different in women with placental abruption. However, there was an increased prevalence of first degree heritage for venous thrombosis in women with placental abruption, indicating a higher prevalence of thrombophilia among women with placental abruption.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742330

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  8 in total

1.  Prevalence of 1691G>A FV mutation in Poland compared with that in other Central, Eastern and South-Eastern European countries.

Authors:  Grażyna Adler; Jeremy S C Clark; Beata Loniewska; Ewa Czerska; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

Review 2.  Novel insights into molecular mechanisms of abruption-induced preterm birth.

Authors:  Catalin S Buhimschi; Frederik Schatz; Graciela Krikun; Irina A Buhimschi; Charles J Lockwood
Journal:  Expert Rev Mol Med       Date:  2010-11-01       Impact factor: 5.600

3.  Low birthweight in relation to placental abruption and maternal thrombophilia status.

Authors:  Carl A Nath; Cande V Ananth; Celeste DeMarco; Anthony M Vintzileos
Journal:  Am J Obstet Gynecol       Date:  2008-01-14       Impact factor: 8.661

4.  Obstetric thromboprophylaxis: the Swedish guidelines.

Authors:  Pelle G Lindqvist; Margareta Hellgren
Journal:  Adv Hematol       Date:  2011-11-22

5.  Allele frequency distribution of 1691G >A F5 (which confers Factor V Leiden) across Europe, including Slavic populations.

Authors:  Jeremy S C Clark; Grażyna Adler; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  J Appl Genet       Date:  2013-11       Impact factor: 3.240

6.  Changing risk factors for placental abruption: A case crossover study using routinely collected data from Finland, Malta and Aberdeen.

Authors:  Emma Anderson; Edwin Amalraj Raja; Ashalatha Shetty; Mika Gissler; Miriam Gatt; Siladitya Bhattacharya; Sohinee Bhattacharya
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

7.  Postpartum thromboembolism: severe events might be preventable using a new risk score model.

Authors:  Pelle G Lindqvist; Jelena Torsson; Asa Almqvist; Ola Björgell
Journal:  Vasc Health Risk Manag       Date:  2008

8.  A population-based study of race-specific risk for placental abruption.

Authors:  Tammy T Shen; Emily A DeFranco; David M Stamilio; Jen Jen Chang; Louis J Muglia
Journal:  BMC Pregnancy Childbirth       Date:  2008-09-12       Impact factor: 3.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.